China Approves Clinical Trial of Omicron Vaccine

By Lars James Hamer, April 28, 2022

0 0

A Chinese vaccination for the Omicron variant of COVID-19 has been approved for clinical trials, reports CGTN.

The vaccine was developed by the China National Biotec Group (which has affiliations with Sinopharm) and was approved by the National Medical Products Administration on Tuesday, April 26. 

Preliminary tests – such as safety evaluations in animals and immunogenicity research – showed that the vaccine is capable of producing antibodies that can fight off COVID variants, including Omicron. 

China National Biotec Group have previously developed COVID-19 vaccines in the country and conducted research into its many variants, including Beta and Delta. 

The trial will be carried out on adults aged 18 and above who have been inoculated with two or three doses of a COVID-19 vaccine.


[Cover image via Flickr]

more news

Zero COVID Cases Reported Outside Quarantine for 3rd Day in Row

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Zero COVID Cases Reported Outside Quarantine for 2nd Day in Row

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Shanghai Reports 0 COVID-19 Cases Outside of Central Quarantine

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Shanghai Reports 1,541 COVID-19 Cases, 1 Not in Quarantine

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Shanghai Reports 1,929 COVID-19 Cases, 4 Not in Quarantine

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Shanghai Reports 1,343 COVID-19 Cases, 2 Not in Quarantine

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Shanghai Reports 0 COVID-19 Cases Outside of Central Quarantine

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

Shanghai Reports 2,858 COVID-19 Cases, 5 Not in Quarantine

The numbers come as Shanghai undergoes China's biggest citywide lockdown since the beginning of the COVID-19 pandemic.

0 User Comments

In Case You Missed It…

We're on WeChat!

Scan our QR Code at right or follow us at Thats_Shanghai for events, guides, giveaways and much more!

7 Days in Shanghai With thatsmags.com

Weekly updates to your email inbox every Wednesday

Subscribe

Download previous issues

Never miss an issue of That's Shanghai!

Visit the archives